These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35061861)

  • 1. Development of β-cyclodextrin/polyvinypyrrolidone-co-poly (2-acrylamide-2-methylpropane sulphonic acid) hybrid nanogels as nano-drug delivery carriers to enhance the solubility of Rosuvastatin: An in vitro and in vivo evaluation.
    Shoukat H; Pervaiz F; Khan M; Rehman S; Akram F; Abid U; Noreen S; Nadeem M; Qaiser R; Ahmad R; Farooq I
    PLoS One; 2022; 17(1):e0263026. PubMed ID: 35061861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of β-cyclodextrin-based hydrogel microparticles for solubility enhancement of rosuvastatin: an in vitro and in vivo evaluation.
    Sarfraz RM; Ahmad M; Mahmood A; Akram MR; Abrar A
    Drug Des Devel Ther; 2017; 11():3083-3096. PubMed ID: 29123380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poloxamer-407-Co-Poly (2-Acrylamido-2-Methylpropane Sulfonic Acid) Cross-linked Nanogels for Solubility Enhancement of Olanzapine: Synthesis, Characterization, and Toxicity Evaluation.
    Khan KU; Akhtar N; Minhas MU
    AAPS PharmSciTech; 2020 May; 21(5):141. PubMed ID: 32419084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosslinked PVA-
    Saleem U; Khalid I; Hussain L; Alshammari A; Albekairi NA
    ACS Omega; 2024 May; 9(19):21401-21415. PubMed ID: 38764664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and Characterization of Carboxymethyl Chitosan Nanosponges with Cyclodextrin Blends for Drug Solubility Improvement.
    Rizvi SSB; Akhtar N; Minhas MU; Mahmood A; Khan KU
    Gels; 2022 Jan; 8(1):. PubMed ID: 35049590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyvinylpyrrolidone K-30-Based Crosslinked Fast Swelling Nanogels: An Impeccable Approach for Drug's Solubility Improvement.
    Minhas MU; Khan KU; Sarfraz M; Badshah SF; Munir A; Barkat K; Basit A; Arafat M
    Biomed Res Int; 2022; 2022():5883239. PubMed ID: 36060130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bi-polymeric Spongy Matrices Through Cross-linking Polymerization: Synthesized and Evaluated for Solubility Enhancement of Acyclovir.
    Asghar S; Akhtar N; Minhas MU; Khan KU
    AAPS PharmSciTech; 2021 Jun; 22(5):181. PubMed ID: 34129154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of PEG-4000-co-poly (AMPS) nanogels by cross-linking polymerization as highly responsive networks for enhancement in meloxicam solubility.
    Khan KU; Minhas MU; Sohail M; Badshah SF; Abdullah O; Khan S; Munir A; Suhail M
    Drug Dev Ind Pharm; 2021 Mar; 47(3):465-476. PubMed ID: 33651645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and Evaluation of Alginate-Based Nanogels as Sustained Drug Carriers for Caffeine.
    Suhail M; Fang CW; Chiu IH; Khan A; Wu YC; Lin IL; Tsai MJ; Wu PC
    ACS Omega; 2023 Jul; 8(26):23991-24002. PubMed ID: 37426260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Porous and highly responsive cross-linked β-cyclodextrin based nanomatrices for improvement in drug dissolution and absorption.
    Badshah SF; Akhtar N; Minhas MU; Khan KU; Khan S; Abdullah O; Naeem A
    Life Sci; 2021 Feb; 267():118931. PubMed ID: 33359243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation, In Vitro Characterization, and Evaluation of Polymeric pH-Responsive Hydrogels for Controlled Drug Release.
    Mahmood T; Sarfraz RM; Mahmood A; Salem-Bekhit MM; Ijaz H; Zaman M; Akram MR; Taha EI; Sahu RK; Benguerba Y
    ACS Omega; 2024 Mar; 9(9):10498-10516. PubMed ID: 38463273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical Delivery of Terbinafine HCL Using Nanogels: A New Approach to Superficial Fungal Infection Treatment.
    Hassan SU; Khalid I; Hussain L; Imam MT; Shahid I
    Gels; 2023 Oct; 9(11):. PubMed ID: 37998931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly Responsive Chitosan-Co-Poly (MAA) Nanomatrices through Cross-Linking Polymerization for Solubility Improvement.
    Saleem A; Akhtar N; Minhas MU; Mahmood A; Khan KU; Abdullah O
    Gels; 2022 Mar; 8(3):. PubMed ID: 35323309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of novel combinatorial drug delivery system (nCDDS) for co-delivery of 5-fluorouracil and leucovorin calcium for colon targeting and controlled drug release.
    Minhas MU; Abdullah O; Sohail M; Khalid I; Ahmad S; Khan KU; Badshah SF
    Drug Dev Ind Pharm; 2021 Dec; 47(12):1952-1965. PubMed ID: 35502653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of β-cyclodextrin hydrogel nanoparticles for improving the solubility of dexibuprofen: characterization and toxicity evaluation.
    Khalid Q; Ahmad M; Minhas MU
    Drug Dev Ind Pharm; 2017 Nov; 43(11):1873-1884. PubMed ID: 28679289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine.
    Lin C; Chen F; Ye T; Zhang L; Zhang W; Liu D; Xiong W; Yang X; Pan W
    Int J Pharm; 2014 Apr; 465(1-2):90-6. PubMed ID: 24530388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Evaluation of Finasteride-Loaded HPMC-Based Nanogels for Transdermal Delivery: A Versatile Nanoscopic Platform.
    Ahmad A; Ahmad M; Minhas MU; Sarfraz M; Sohail M; Khan KU; Tanveer S; Ijaz S
    Biomed Res Int; 2022; 2022():2426960. PubMed ID: 35909483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carboxylate cross-linked cyclodextrin: A nanoporous scaffold for enhancement of rosuvastatin oral bioavailability.
    Gabr MM; Mortada SM; Sallam MA
    Eur J Pharm Sci; 2018 Jan; 111():1-12. PubMed ID: 28931488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, characterization and pharmacokinetic evaluation of rosuvastatin calcium incorporated cyclodextrin-polyanhydride nanoparticles.
    Al-Heibshy FNS; Başaran E; Arslan R; Öztürk N; Vural İ; Demirel M
    Drug Dev Ind Pharm; 2019 Oct; 45(10):1635-1645. PubMed ID: 31342792
    [No Abstract]   [Full Text] [Related]  

  • 20. Preparation and
    Al-Heibshy FNS; Başaran E; Öztürk N; Demirel M
    Drug Dev Ind Pharm; 2020 Sep; 46(9):1495-1506. PubMed ID: 32804005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.